News and Trends 14 Jul 2023
Calliditas reveals ‘encouraging results’ from head and neck cancer trial
Calliditas Therapeutics AB has announced interim data from its proof-of-concept phase 2 trial in patients with squamous cell carcinoma of the head and neck (SCCHN) with its lead NOX 1…